December 22, 2008

ELI LILLY: Appeal to Ruling on Ariad ‘516 Patent Claims Pending

COMPANIES: Eli Lilly & Co
Subscribe

Eli Lilly and Co.’s appeal from the September 2007 final judgment indicating that Ariad Pharmaceuticals Inc.’s claims are patentable, valid, and enforceable remains pending.

In June 2002, Ariad Pharmaceuticals Inc., the…

TO CONTINUE READING,LOGIN or
TOPICS: Biotechnology | Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: Indiana | United States